Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001144204-14-059507
Filing Date
2014-10-03
Accepted
2014-10-03 16:28:10
Documents
5
Period of Report
2013-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K/A v390704_10ka.htm 10-K/A 23250
2 EXHIBIT 10.30 v390704_ex10-30.htm EX-10.30 592284
3 EXHIBIT 31.1.1 v390704_ex31-11.htm EX-31.1.1 3644
4 EXHIBIT 31.2.1 v390704_ex31-21.htm EX-31.2.1 3737
5 GRAPHIC tpg71.jpg GRAPHIC 10212
  Complete submission text file 0001144204-14-059507.txt   638280
Mailing Address CAMBRIDGE INNOVATION CENTER ONE BROADWAY, 14TH FLOOR CAMBRIDGE MA 02142
Business Address CAMBRIDGE INNOVATION CENTER ONE BROADWAY, 14TH FLOOR CAMBRIDGE MA 02142 914-606-3500
IMMUNE PHARMACEUTICALS INC (Filer) CIK: 0001208261 (see all company filings)

EIN.: 521841431 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-36602 | Film No.: 141140125
SIC: 2834 Pharmaceutical Preparations